{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:26:52Z","timestamp":1787020012541,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["81270353"],"award-info":[{"award-number":["81270353"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["81160001"],"award-info":[{"award-number":["81160001"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12872-017-0596-0","type":"journal-article","created":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T08:31:34Z","timestamp":1497947494000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Expression levels of atherosclerosis-associated miR-143 and miR-145 in the plasma of patients with hyperhomocysteinaemia"],"prefix":"10.1186","volume":"17","author":[{"given":"Kejian","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saiyare","family":"Xuekelati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangdong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1511-6914","authenticated-orcid":false,"given":"Xiaomei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,20]]},"reference":[{"issue":"8","key":"596_CR1","doi-asserted-by":"crossref","first-page":"17682","DOI":"10.3390\/ijms160817682","volume":"16","author":"F Li","year":"2015","unstructured":"Li F, Chen Q, Song X, Zhou L, Zhang J. MiR-30b is involved in the Homocysteine-induced apoptosis in human coronary artery endothelial cells by regulating the expression of Caspase 3. Int J Mol Sci. 2015;16(8):17682\u201395.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"596_CR2","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.thromres.2014.05.025","volume":"134","author":"A Schaffer","year":"2014","unstructured":"Schaffer A, et al. Relationship between homocysteine and coronary artery disease. Results from a large prospective cohort study. Thromb Res. 2014;134(2):288\u201393.","journal-title":"Thromb Res"},{"issue":"9","key":"596_CR3","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/00007611-199909000-00002","volume":"92","author":"MA Alpert","year":"1999","unstructured":"Alpert MA. Homocyst(e)ine, atherosclerosis, and thrombosis. South Med J. 1999;92(9):858\u201365.","journal-title":"South Med J"},{"issue":"8","key":"596_CR4","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1212\/WNL.0000000000000720","volume":"83","author":"SB Jeon","year":"2014","unstructured":"Jeon SB, Kang DW, Kim JS, Kwon SU. Homocysteine, small-vessel disease, and atherosclerosis: an MRI study of 825 stroke patients. Neurol. 2014;83(8):695\u2013701.","journal-title":"Neurol"},{"issue":"6","key":"596_CR5","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/FJC.0000000000000370","volume":"67","author":"L Meng","year":"2016","unstructured":"Meng L, et al. Polyphenols and polypeptides in Chinese Rice wine inhibit Homocysteine-induced proliferation and migration of vascular smooth muscle cells. J Cardiovasc Pharmacol. 2016;67(6):482\u201390.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"2","key":"596_CR6","first-page":"86","volume":"39","author":"A Rudijanto","year":"2007","unstructured":"Rudijanto A. The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis. Acta medica Indonesiana. 2007;39(2):86\u201393.","journal-title":"Acta medica Indonesiana"},{"issue":"2","key":"596_CR7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/MOL.0000000000000279","volume":"27","author":"JA Dubland","year":"2016","unstructured":"Dubland JA, Francis GA. So much cholesterol: the unrecognized importance of smooth muscle cells in atherosclerotic foam cell formation. Curr Opin Lipidol. 2016;27(2):155\u201361.","journal-title":"Curr Opin Lipidol"},{"issue":"6","key":"596_CR8","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1007\/s12265-013-9493-9","volume":"6","author":"JC Deddens","year":"2013","unstructured":"Deddens JC, et al. Circulating MicroRNAs as novel biomarkers for the early diagnosis of acute coronary syndrome. J Cardiovasc Transl Res. 2013;6(6):884\u201398.","journal-title":"J Cardiovasc Transl Res"},{"key":"596_CR9","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.cca.2016.06.044","volume":"460","author":"Y Gao","year":"2016","unstructured":"Gao Y, et al. Functional regulatory roles of microRNAs in atherosclerosis. Clin Chim Acta. 2016;460:164\u201371.","journal-title":"Clin Chim Acta"},{"issue":"6","key":"596_CR10","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/joim.12298","volume":"276","author":"L Maegdefessel","year":"2014","unstructured":"Maegdefessel L. The emerging role of microRNAs in cardiovascular disease. J Intern Med. 2014;276(6):633\u201344.","journal-title":"J Intern Med"},{"issue":"10","key":"596_CR11","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/1440-1681.12611","volume":"43","author":"H Duan","year":"2016","unstructured":"Duan H, et al. MicroRNA-217 suppresses homocysteine-induced proliferation and migration of vascular smooth muscle cells via N-methyl-D-aspartic acid receptor inhibition. Clin Exp Pharmacol Physiol. 2016;43(10):967\u201375.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"7256","key":"596_CR12","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nature08195","volume":"460","author":"K Cordes","year":"2009","unstructured":"Cordes K, Sheehy R. N.T, white M.P. et al. MiR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nat. 2009;460(7256):705\u201310.","journal-title":"Nat"},{"issue":"1","key":"596_CR13","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3892\/mmr.2015.4558","volume":"13","author":"HP Zhang","year":"2016","unstructured":"Zhang HP, et al. A regulatory circuit involving miR-143 and DNMT3a mediates vascular smooth muscle cell proliferation induced by homocysteine. Mol Med Rep. 2016;13(1):483\u201390.","journal-title":"Mol Med Rep"},{"issue":"9","key":"596_CR14","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1172\/JCI38864","volume":"119","author":"T Boettger","year":"2009","unstructured":"Boettger T, et al. Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143\/145 gene cluster. J Clin Investig. 2009;119(9):2634\u201347.","journal-title":"J Clin Investig"},{"key":"596_CR15","doi-asserted-by":"crossref","first-page":"35302","DOI":"10.1038\/srep35302","volume":"6","author":"X Guo","year":"2016","unstructured":"Guo X, et al. MiRNA-145 inhibits VSMC proliferation by targeting CD40. Sci Rep. 2016;6:35302.","journal-title":"Sci Rep"},{"issue":"3","key":"596_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0058159","volume":"8","author":"C Shimizu","year":"2013","unstructured":"Shimizu C, et al. Differential expression of miR-145 in children with Kawasaki disease. PLoS One. 2013;8(3):1\u201312.","journal-title":"PLoS One"},{"issue":"4","key":"596_CR17","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/cvr\/cvn156","volume":"79","author":"C Urbich","year":"2008","unstructured":"Urbich C, Kuehbacher A, Dimmeler S. Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc Res. 2008;79(4):581\u20138.","journal-title":"Cardiovasc Res"},{"issue":"6","key":"596_CR18","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/MOL.0000000000000358","volume":"27","author":"A Baldan","year":"2016","unstructured":"Baldan A, Fernandez-Hernando C. Truths and controversies concerning the role of miRNAs in atherosclerosis and lipid metabolism. Curr Opin Lipidol. 2016;27(6):623\u20139.","journal-title":"Curr Opin Lipidol"},{"issue":"8","key":"596_CR19","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/jhh.2013.117","volume":"28","author":"JE Kontaraki","year":"2014","unstructured":"Kontaraki JE, Marketou ME, Zacharis EA, et al. Differential expression of vascular smooth muscle-modulating microRNAs in human peripheral blood mononuclear cells: novel targets in essential hypertension. J Hum Hypertens. 2014;28(8):510\u20136.","journal-title":"J Hum Hypertens"},{"issue":"7","key":"596_CR20","first-page":"1813","volume":"7","author":"X Fu","year":"2014","unstructured":"Fu X, Guo L, Jiang ZM, et al. An miR-143 promoter variant associated with essential hypertension. Int J Clin Exp Med. 2014;7(7):1813\u20137.","journal-title":"Int J Clin Exp Med"},{"issue":"5","key":"596_CR21","doi-asserted-by":"crossref","first-page":"e96338","DOI":"10.1371\/journal.pone.0096338","volume":"9","author":"B Hu","year":"2014","unstructured":"Hu B, Song JT, Qu HY, et al. Mechanical stretch suppresses microRNA-145 expression by activating extracellular signalregulated kinase 1\/2 and upregulating angiotensin-converting enzyme to alter vascular smooth muscle cell phenotype. PLoS One. 2014;9(5):e96338.","journal-title":"PLoS One"},{"issue":"23","key":"596_CR22","doi-asserted-by":"crossref","first-page":"19199","DOI":"10.1074\/jbc.M112.341073","volume":"287","author":"KM Turczynska","year":"2012","unstructured":"Turczynska KM, Sadegh MK, Hellstrand P, et al. MicroRNAs are essential for stretch-induced vascular smooth muscle contractile differentiation via microRNA (miR)-145-dependent expression of L-type calcium channels. J Biol Chem. 2012;287(23):19199\u2013206.","journal-title":"J Biol Chem"},{"key":"596_CR23","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature10146","volume":"473","author":"P Libby","year":"2011","unstructured":"Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nat. 2011;473:317\u201325.","journal-title":"Nat"},{"key":"596_CR24","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1101\/gad.1842409","volume":"23","author":"M Xin","year":"2009","unstructured":"Xin M, Small EM, Sutherland LB, et al. MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury. Genes Dev. 2009;23:2166\u201378.","journal-title":"Genes Dev"},{"key":"596_CR25","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1161\/CIRCRESAHA.109.197517","volume":"105","author":"Y Cheng","year":"2009","unstructured":"Cheng Y, Liu X, Yang J, et al. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ Res. 2009;105:158\u201366.","journal-title":"Circ Res"},{"issue":"1\u20132","key":"596_CR26","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s11010-015-2383-5","volume":"404","author":"V Kesherwani","year":"2015","unstructured":"Kesherwani V, Nandi SS, Sharawat SK, Shahshahan HR, Mishra PK. Hydrogen sulfide mitigates homocysteine-mediated pathological remodeling by inducing miR-133a in cardiomyocytes. Mol Cell Biochem. 2015;404(1\u20132):241\u201350.","journal-title":"Mol Cell Biochem"},{"issue":"6","key":"596_CR27","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.pjnns.2016.07.002","volume":"50","author":"A Arslan","year":"2016","unstructured":"Arslan A, et al. The relationship between serum paraoxonase levels and carotid atherosclerotic plaque formation in Alzheimer's patients. Neurol Neurochir Pol. 2016;50(6):403\u20139.","journal-title":"Neurol Neurochir Pol"},{"issue":"1","key":"596_CR28","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1373\/clinchem.2013.213066","volume":"60","author":"JD Kuhlmann","year":"2014","unstructured":"Kuhlmann JD, et al. Circulating U2 small nuclear RNA fragments as a novel diagnostic tool for patients with epithelial ovarian cancer. Clin Chem. 2014;60(1):206\u201313.","journal-title":"Clin Chem"},{"issue":"2","key":"596_CR29","doi-asserted-by":"crossref","first-page":"E48","DOI":"10.1002\/ijc.27791","volume":"132","author":"A Baraniskin","year":"2013","unstructured":"Baraniskin A, et al. Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for pancreatic and colorectal adenocarcinoma. Int J Cancer. 2013;132(2):E48\u201357.","journal-title":"Int J Cancer"},{"issue":"6","key":"596_CR30","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/eurheartj\/ehq013","volume":"31","author":"GK Wang","year":"2010","unstructured":"Wang GK, et al. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J. 2010;31(6):659\u201366.","journal-title":"Eur Heart J"},{"issue":"11","key":"596_CR31","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1161\/CIRCULATIONAHA.111.084186","volume":"126","author":"F Lovren","year":"2012","unstructured":"Lovren F, et al. MicroRNA-145 targeted therapy reduces atherosclerosis. Circ. 2012;126(11):S81\u201390.","journal-title":"Circ"},{"issue":"4","key":"596_CR32","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1160\/TH13-11-0905","volume":"112","author":"F Sala","year":"2014","unstructured":"Sala F, et al. MiR-143\/145 deficiency attenuates the progression of atherosclerosis in Ldlr\u2212\/\u2212mice. Thromb Haemost. 2014;112(4):796\u2013802.","journal-title":"Thromb Haemost"},{"issue":"2","key":"596_CR33","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1161\/CIRCGENETICS.110.958702","volume":"4","author":"AY Rangrez","year":"2014","unstructured":"Rangrez AY, Massy ZA, Metzinger-Le Meuth V, Metzinger L. MiR-143 and miR-145: molecular keys to switch the phenotype of vascular smooth muscle cells. Circ Cardiovasc Genet. 2014;4(2):197\u2013205.","journal-title":"Circ Cardiovasc Genet"},{"issue":"4","key":"596_CR34","doi-asserted-by":"crossref","first-page":"526","DOI":"10.3349\/ymj.2010.51.4.526","volume":"51","author":"H Seo","year":"2010","unstructured":"Seo H, Oh H, Park H, et al. Contribution of dietary intakes of antioxidants to homocysteine-induced low density lipoprotein (LDL) oxidation in atherosclerotic patients. Yonsei Med J. 2010;51(4):526\u201333.","journal-title":"Yonsei Med J"},{"issue":"1","key":"596_CR35","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/nyas.13009","volume":"1363","author":"I Chernyavskiy","year":"2016","unstructured":"Chernyavskiy I, Veeranki S, Sen U, Tyagi SC. Atherogenesis: hyperhomocysteinemia interactions with LDL, macrophage function, paraoxonase 1, and exercise. Ann N Y Acad Sci. 2016;1363(1):138\u201354.","journal-title":"Ann N Y Acad Sci"},{"key":"596_CR36","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1475-2891-14-6","volume":"14","author":"P Ganguly","year":"2015","unstructured":"Ganguly P, Alam SF. Role of homocysteine in the development of cardiovascular disease. Nutr J. 2015;14:6.","journal-title":"Nutr J"},{"issue":"5","key":"596_CR37","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.clinthera.2016.03.007","volume":"38","author":"H Pang","year":"2016","unstructured":"Pang H, Han B, Fu Q, Zong Z. Association of High Homocysteine Levels with the risk stratification in hypertensive patients at risk of stroke. Clin Ther. 2016;38(5):1184\u201392.","journal-title":"Clin Ther"},{"issue":"4","key":"596_CR38","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/cvr\/cvw174","volume":"111","author":"R Navickas","year":"2016","unstructured":"Navickas R, et al. Identifying circulating microRNAs as biomarkers of cardiovascular disease: a systematic review. Cardiovasc Res. 2016;111(4):322\u201337.","journal-title":"Cardiovasc Res"},{"issue":"3","key":"596_CR39","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1517\/14728222.2013.745512","volume":"17","author":"D Santovito","year":"2013","unstructured":"Santovito D, et al. Overexpression of microRNA-145 in atherosclerotic plaques from hypertensive patients. Expert Opin Ther Targets. 2013;17(3):217\u201323.","journal-title":"Expert Opin Ther Targets"},{"issue":"6","key":"596_CR40","doi-asserted-by":"crossref","first-page":"e000407","DOI":"10.1161\/JAHA.113.000407","volume":"2","author":"X Liu","year":"2013","unstructured":"Liu X, et al. Flank sequences of miR-145\/143 and their aberrant expression in vascular disease: mechanism and therapeutic application. J Am Heart Assoc. 2013;2(6):e000407.","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"596_CR41","doi-asserted-by":"crossref","first-page":"e0123477","DOI":"10.1371\/journal.pone.0123477","volume":"10","author":"H Gao","year":"2015","unstructured":"Gao H, et al. Plasma levels of microRNA-145 are associated with severity of coronary artery disease. PLoS One. 2015;10(5):e0123477.","journal-title":"PLoS One"},{"issue":"11","key":"596_CR42","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nrd3864","volume":"11","author":"E Rooij van","year":"2012","unstructured":"van Rooij E, Olson EN. MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles. Nat Rev Drug Discov. 2012;11(11):860\u201372.","journal-title":"Nat Rev Drug Discov"},{"key":"596_CR43","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-pharmtox-011613-135957","volume":"54","author":"S Dangwal","year":"2014","unstructured":"Dangwal S, Tum T. MicroRNA therapeutics in cardiovascular disease models. Annu Rev Pharmacol Toxicol. 2014;54:185\u2013203.","journal-title":"Annu Rev Pharmacol Toxicol"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-017-0596-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T17:54:58Z","timestamp":1659117298000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-017-0596-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,20]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["596"],"URL":"https:\/\/doi.org\/10.1186\/s12872-017-0596-0","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,20]]},"article-number":"163"}}